These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. [Aiming for a breakthrough in therapy for cerebrovascular disorders]. Takahashi S; del Zoppo GJ Rinsho Shinkeigaku; 2010 Nov; 50(11):875. PubMed ID: 21921484 [No Abstract] [Full Text] [Related]
67. New approach to treatment of recent stroke? Perkin GD Br Med J; 1979 Jun; 1(6178):1628. PubMed ID: 466158 [No Abstract] [Full Text] [Related]
68. Is there a role for naloxone in the treatment of stroke? Martinez-Arizola A; Holaday JW Crit Care Med; 1989 Aug; 17(8):839-40. PubMed ID: 2752782 [No Abstract] [Full Text] [Related]
70. Cardiogenic stroke in the elderly. Davis WD; Hart RG Clin Geriatr Med; 1991 Aug; 7(3):429-42. PubMed ID: 1868402 [TBL] [Abstract][Full Text] [Related]
71. Serum S100B indicates successful combination treatment with recombinant tissue plasminogen activator and MK-801 in a rat model of embolic stroke. Tanaka Y; Marumo T; Omura T; Yoshida S Brain Res; 2007 Jun; 1154():194-9. PubMed ID: 17475227 [TBL] [Abstract][Full Text] [Related]
72. [New concepts in the treatment of ischemic stroke]. Wei G Zhonghua Nei Ke Za Zhi; 1996 Aug; 35(8):509-11. PubMed ID: 9594137 [No Abstract] [Full Text] [Related]
73. Does effect of a neuroprotective agent on volume of experimental animal cerebral infarct predict effect of the agent on clinical outcome in human stroke? Jonas S; Tran AQ; Eisenberg E; Azam M; Viera D; Grumet S Ann N Y Acad Sci; 1997 Oct; 825():281-7. PubMed ID: 9369994 [No Abstract] [Full Text] [Related]